The Valley Desk

ArticleFrontiers in oncologyPublished

KEAP1 mutations activate the NRF2 pathway to drive cell growth and migration, and attenuate drug response in thyroid cancer

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Frontiers in oncology
Published
Subject terms
Mutation; LOH; Pediatric; Thyroid cancer; NRF2; Keap1; Selpercatinib; Chr19p
PubMed ID
41573641
PubMed Central ID
PMC12819188
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal